What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
After A 97% Fall, Could Carvana Shares Be Heading To 10 Cents? Here's Why One Analyst Thinks So
Why This Analyst Thinks 'Fed Pivot Trade' Could Go Into Overdrive On Friday — It's Linked To Sept Jobs Data
Apple Hypes 'Far Out' Event For September, But This Analyst Says There's A 'Bigger Story'
Termination Recent News
McDonald's To $278? Analysts Just Raised Their Price Targets On These 5 Stocks
A 'More Aggressive Approach': Ericsson Notches Upgrade After Q1 Print
Taking Profits In Financials? Proceed With Caution
Why There Could Be Upside To Current Expectations For Denny's Q3
Street Speculates 2 Suitors Courting NXP Semiconductors
Bernstein Suspends Coverage Of Hain Celestial Amid Accounting Issues Announcement
4 Key Takeaways From Marvell Technology's Q1 Results
Wall Street Analysts Fleeing LendingClub: Stifel Downgrades, William Blair Drops Coverage
The Only Firm That Was Bearish On Chimerix Before The Selloff
Morgan Stanley Slashes Deepwater Drillers, Says They're 'Fighting Tooth And Nail' To Stay Afloat
Analysts Like Cabelas Despite Recent Disappointments
Stifel Terminates Coverage On Oncolytics Biotech Due To Reallocation Of Resources
Stifel Terminates Coverage On GTx Due To Reallocation Of Resources